• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493941832300
Device Problems Difficult to Remove (1528); Failure to Advance (2524); Device Dislodged or Dislocated (2923)
Patient Problems Pain (1994); Discomfort (2330)
Event Date 09/30/2022
Event Type  malfunction  
Event Description
It was reported that stent dislodgment occurred.The patient underwent computed tomography (ct) turn down complex multivessel percutaneous coronary intervention.The target lesion was located in the left anterior descending artery.A 3.00 x 32mm synergy xd drug-eluting stent (des) was advanced but failed to cross the lesion.During withdrawal, the stent was dislodged off the balloon in the radial artery and the entire system was pulled from radial access.The patient felt discomfort and pain.Eventually, a 2.5 x 24 synergy xd/ 3.0 x 38 synergy xd and a 4.5 x 16 synergy xd des were used to treat multivessel disease and the procedure was completed with a 3.0 x 38 synergy xd des.The patient was doing well and fully recovered post-procedure.
 
Event Description
It was reported that stent dislodgment occurred.The patient underwent computed tomography (ct) turn down complex multivessel percutaneous coronary intervention.The target lesion was located in the left anterior descending artery.A 3.00 x 32mm synergy xd drug-eluting stent (des) was advanced but failed to cross the lesion.During withdrawal, the stent was dislodged off the balloon in the radial artery and the entire system was pulled from radial access.The patient felt discomfort and pain.Eventually, a 2.5 x 24 synergy xd/ 3.0 x 38 synergy xd and a 4.5 x 16 synergy xd des were used to treat multivessel disease and the procedure was completed with a 3.0 x 38 synergy xd des.The patient was doing well and fully recovered post-procedure.It was further reported that the target lesion was calcified and tortuous.Additionally, radial access issues were encountered before and after the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key15631616
MDR Text Key303624554
Report Number2124215-2022-41392
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08714729981008
UDI-Public08714729981008
Combination Product (y/n)Y
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/19/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/26/2023
Device Model NumberH7493941832300
Device Lot Number0028311656
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/19/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age63 YR
Patient SexFemale
-
-